Results 41 to 50 of about 583,625 (325)
Virus-Like Particle Production in Atmospheric Eubacteria Isolates
Atmosphere, 2019 Culturable eubacterial isolates were collected at various altitudes in Earth’s atmosphere, including ~1.5 m above ground in Tallahassee, FL, USA; ~10.0 m above sea level over the mid-Atlantic ridge (~15° N); ~20 km above ground over the ...
Nuria Teigell-Perez +4 more
doaj +1 more source
Vaccines, 2021 Virus-like particles (VLPs) are non-replicative vectors for the delivery of heterologous epitopes and are considered one of the most potent inducers of cellular and humoral immune responses in mice and guinea pigs.
Muhammad Naveed Anwar +14 more
doaj +1 more source
Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. [PDF]
PLoS ONE, 2010 The 2009 influenza pandemic and shortages in vaccine supplies worldwide underscore the need for new approaches to develop more effective vaccines.We generated influenza virus-like particles (VLPs) containing proteins derived from the A/California/04/2009
Fu-Shi Quan +3 more
doaj +1 more source
Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine [PDF]
, 2014 Dengue virus (DENV), composed of four distinct serotypes, is the most important and rapidly emerging arthropod-borne pathogen and imposes substantial economic and public health burdens.
Chang, Gwong-Jen J +4 more
core +1 more source
The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference
Expert Review of Vaccines, 2019 Virus-like particles (VLPs) and nano-particles (NPs) are promising vaccine platforms that have led to the successful development of commercially available vaccines.
Paul Engeroff, Martin F. Bachmann
doaj +1 more source
Escherichia coli-derived virus-like particles in vaccine development
npj Vaccines, 2017 Recombinant virus-like particle-based vaccines are composed of viral structural proteins and mimic authentic native viruses but are devoid of viral genetic materials. They are the active components in highly safe and effective vaccines for the prevention
Xiaofen Huang +4 more
doaj +1 more source
PLoS ONE, 2019 Background New influenza vaccines eliciting more effective protection are needed, particularly for the elderly who paid a large and disproportional toll of hospitalization and dead during seasonal influenza epidemics.
S. Pillet +7 more
semanticscholar +1 more source
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
Viruses, 2020 Hepatitis B remains one of the major global health problems more than 40 years after the identification of human hepatitis B virus (HBV) as the causative agent.
Joan Kha-Tu Ho +2 more
doaj +1 more source
Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1. [PDF]
PLoS ONE, 2016 An outbreak of influenza H1N1 in 2009, representing the first influenza pandemic of the 21st century, was transmitted to over a million individuals and claimed 18,449 lives.
Yong-Dae Gwon +9 more
doaj +1 more source
Multiplex Human Papillomavirus L1L2 virus-like particle antibody binding assay
MethodsX, 2022 A variety of in vitro techniques are available to estimate the level of antibodies present in human serum samples. Such tests are highly specific and are used to determine prior exposure to a pathogen or to estimate the magnitude, breadth and durability ...
Kavita Panwar +7 more
doaj +1 more source